U.S. markets closed
  • S&P 500

    4,422.30
    +10.51 (+0.24%)
     
  • Dow 30

    35,144.31
    +82.76 (+0.24%)
     
  • Nasdaq

    14,840.71
    +3.72 (+0.03%)
     
  • Russell 2000

    2,216.92
    +7.27 (+0.33%)
     
  • Crude Oil

    72.18
    +0.11 (+0.15%)
     
  • Gold

    1,797.70
    -4.10 (-0.23%)
     
  • Silver

    25.26
    +0.03 (+0.11%)
     
  • EUR/USD

    1.1806
    +0.0036 (+0.31%)
     
  • 10-Yr Bond

    1.2760
    -0.0100 (-0.78%)
     
  • GBP/USD

    1.3821
    +0.0067 (+0.49%)
     
  • USD/JPY

    110.3700
    -0.1400 (-0.13%)
     
  • BTC-USD

    37,483.50
    +3,067.62 (+8.91%)
     
  • CMC Crypto 200

    905.01
    -10.48 (-1.14%)
     
  • FTSE 100

    7,025.43
    -2.15 (-0.03%)
     
  • Nikkei 225

    27,833.29
    +285.29 (+1.04%)
     

Pfizer partners with South Africa to produce pneumococcal vaccine

CAPE TOWN, Nov 3 (Reuters) - Global pharmaceutical company, Pfizer, has partnered with South Africa's Biovac Institute to produce a potentially life-saving pneumonia vaccine for infants, a cabinet minister said on Tuesday.

The five-year partnership, officially announced at Biovac's Cape Town facility, will see technology transfer and skills upgraded for the production of 'Prevenar 13' vaccine on a sustainable basis, Science and Technology Minister Naledi Pandor said.

(Reporting by Wendell Roelf; Editing by James Macharia)